Phase II Proof-of-concept Study of APD421

Clinical trial NCT01303978 · COMPLETED

Trial details

NCT number: NCT01303978
Sponsor: Acacia Pharma Ltd
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chemotherapy-induced Nausea and Vomiting

Start date: 2011-02-01
Primary completion: 2012-07-01
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.